New Skin Toxicities for New Anticancer Therapies - Image 1

£70.62

Nova Science Publishers Inc New Skin Toxicities for New Anticancer Therapies

Name: New Skin Toxicities for New Anticancer Therapies
Brand: Nova Science Publishers Inc
Price: 70.62 GBP
Availability: InStock

Allied Health Professions

This is the usual price. Wait for it to drop, or tell us your number.

£71 today · usual range £43–£105 · best ever £43

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 75 days • 6 price levels

Days at Price

Current Price

Price Analysis

Most common price: £105 (29 days, 38.7%)

Price range: £43 - £105

Price levels: 6 different prices over 75 days

Description

Targeted cancer therapies have revolutionised the therapeutic management of many neoplasms, modifying patients' prognosis and overall survival. These drugs block the cancer's growth and spread by interfering with specific molecules which play a crucial role in the proliferation, differentiation and survival of cancer cells. Targeted therapies act selectively on specific molecular targets related to cancers, whereas most of the conventional chemotherapies act on all rapidly dividing normal and neoplastic cells. Moreover, targeted therapies are often cytostatic and non-cytotoxic as standard chemotherapies. Taken together, these aspects appear important in reducing systemic toxicity and ensuring an improved safety profile. The inhibition of epidermal growth factor receptor (EGFR), vascular growth factor (VEGF) and BRAF represents major achievements in research and development of solid tumour's epithelial therapy. This class of biologics is currently widely used in the treatment of metastatic and unresponsive neoplasms of the colon, pancreas, lung, (NSCLC), breast, head and neck and melanoma. This book aims to emphasize skin toxicity associated with EGFR-, VEGF- and BRAF- inhibitors, focusing particularly on their clinical presentation, histopathological findings, and specific therapeutic options.

Product Specifications

Brand: Nova Science Publishers Inc
Format: paperback
ASIN: 1634822242
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions
Domain: Amazon UK
Release Date: 01 June 2015
Listed Since: 12 February 2015

Barcode

No barcode data available

Nova Science Publishers Inc New Skin Toxicities for New Anticancer Therapies

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Targeted Cancer Therapy: A Ha: A Handbook for Nurses

New Trends in the Molecular and Biological Basis for Clinical Oncology

Neuro-Oncology & Cancer Targeted Therapy (Cancer Etiology, Diagnosis & Treatments Series)

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Cancer Chemotherapy: Basic Science to the Clinic

New Therapies in Advanced Cutaneous Malignancies

Handbook of Targeted Cancer Therapy and Immunotherapy

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Molecular Targets in Cancer Therapy: Understanding Cellular Pathways for Therapeutic Interventions

Springer - Molecular Therapies of Cancer Textbook

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Small Molecules for Cancer Treatment

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Handbook of Skin Care in Cancer Patients (Cancer Etiology, Diagnosis and Treatments)

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology)

Therapeutic Strategies in Cancer Biology and Pathology

Cancer Chemotherapy, Immunotherapy, and Biotherapy

Dermatologic Reactions to Cancer Therapies (Series in Dermatological Treatment)

Humana Molecular Targeting in Oncology - Cancer Drug Book

Targeted Therapies in Cancer (Cancer Etiology Diagnosis and Treatments)

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice

Dermatologic Reactions to Cancer Therapies (Series in Dermatological Treatment)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy (Volume 4)